Researchers from A*STAR and partner institutions have identified how Mycobacterium abscessus develops resistance to bacteriophage therapy and proposed a strategy to address this challenge.

• Mechanism: “Smooth” bacterial strains can transition to a “rough” form through genetic mutations, reducing susceptibility to phage therapy.
• Research Scope: Findings are based on laboratory and pre-clinical models examining bacterial response to treatment.
• Clinical Relevance: The study supports the development of improved therapeutic strategies and diagnostic approaches for antimicrobial resistance.

This summary is based on a news article published by BioSpectrum Asia.

Image for illustrative purposes only. Source: Canva.